Chemotherapy with gemcitabine for unresectable intrahepatic cholangiocarcinoma in a patient undergoing maintenance hemodialysis-Reference-Cited by-同舟云学术

Chemotherapy with gemcitabine for unresectable intrahepatic cholangiocarcinoma in a patient undergoing maintenance hemodialysis

Published:2021-07-09 Issue:5 Volume:14 Page:1511-1516
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Matsumoto Kotaro^ORCID,Okamoto Kanji,Namura Yuta,Kikuyama Tomohiro,Saito Go,Adachi Takako,Watanabe Ayako,Tsunashima Hiromichi,Katsukura Nobuhiro,Tsujikawa Takayuki,Kikuchi Kentaro,Matsui Katsuyuki,Doi Shinpei

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-021-01478-4.pdf

Reference13 articles.

1. Nitta K, Goto S, Masakane I, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. 2020;6:41.

2. Kaizu K. Prevalence of malignancies in digestive organs of dialysis patients: diseases of alimentary Tract in Maintenance Dialysis Patients. Jpn J Clin Dial. 2006;22:1123–9.

3. Chien CC, Han MM, Chiu YH, et al. Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer. 2017;8:9–18.

4. Nagino M, Hirano S, Yoshitomi H, et al. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci. 2021;28:26–54.

5. Kiani A, Köhne CH, Franz T, et al. Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment. Cancer Chemother Pharmacol. 2003;51:266–70.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine;Reactions Weekly;2021-08